Pharmacosmos
Pharmacosmos A/S, a leading player in the pharmaceutical industry, is headquartered in Denmark (DK) and operates extensively across Europe and beyond. Founded in 1983, the company has established itself as a specialist in iron deficiency treatment, focusing on innovative therapies that enhance patient care. Pharmacosmos is renowned for its core products, including intravenous iron formulations, which are distinguished by their efficacy and safety profiles. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted partner in the healthcare sector. With a strong market presence and a dedication to improving patient outcomes, Pharmacosmos continues to make notable contributions to the treatment of iron deficiency and related conditions.
DitchCarbon Score
How does Pharmacosmos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmacosmos's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmacosmos's reported carbon emissions
Pharmacosmos, headquartered in Denmark (DK), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Pharmacosmos may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information at this time. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and climate action, often setting science-based targets to align with global climate goals. However, without specific emissions data or commitments from Pharmacosmos, it is unclear how the company is addressing its environmental impact or contributing to broader climate initiatives.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmacosmos is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
